Faculty of Pharmaceutical Sciences

Activities

Activities per year 1990 2011 2012 2013 2014 2015 2016 2017 2018 2025

• 2140 Oral presentation
• 78 social activities
• 52 Academic activities
• 18 Invited talk
• 12 More
  • 5 Other reseach activity
  • 5 Other educational activity
  • 1 Participating in a conference, workshop
  • 1 Editorial work

Activities per year

Search results

• Aβ impairs memory in mice via tumor necrosis factor-α.

  Nitta, A. (Speaker)

  2006/09/01 → 2006/09/02

  Activity: Talk or presentation › Oral presentation

• Aβ処置マウス海馬でのニューロフィラメントLが過剰にニトロ化されると認知障害が誘導される

  Nitta, A. (Speaker)

  2008/09/11 → 2008/09/13

  Activity: Talk or presentation › Oral presentation

• BAX/BAKに着目した悪性黒色腫に対する新規薬剤併用法の探索

  Yokoyama, S. (Speaker)

  2015/06

  Activity: Talk or presentation › Oral presentation

• BDNF遺伝子欠損マウス由来培養海馬神経細胞におけるBDNF応答性の低下

  Nitta, A. (Speaker)

  2001/09/26 → 2001/09/28

  Activity: Talk or presentation › Oral presentation

• BDNF遺伝子発現を誘導するピレスロイド殺虫剤の作用機序と構造活性相関に関する解析

  Ihara, D. (Speaker)

  2009/12

  Activity: Talk or presentation › Oral presentation

• Behavioral and electrophysiological analyses of spial nociceptive transmission in a murine model of cancer-induced bone pain.

  Uta, D. (Speaker)

  2008/11/15 → 2008/11/19

  Activity: Talk or presentation › Oral presentation

• Behavioral and electrophysiological studies of the peripheral neuropathy induced by paclitaxel in mouse

  Uta, D. (Speaker)

  2021/09/15 → 2021/09/17

  Activity: Talk or presentation › Oral presentation

• Behavioral and neurobiochemical changes in olfactory bulbectomized rats: Antidepressive effects of sigma1 receptor agonist, SA-4503.

  Nitta, A. (Speaker)

  2005/08/08

  Activity: Talk or presentation › Oral presentation

• Behavioral and neurochemical analyses in the Piccolo knockdown mice as a new animal model for schizophrenia.

  Nitta, A. (Speaker)

  2018/07/01 → 2018/07/06

  Activity: Talk or presentation › Oral presentation

• Behavioral impairment associated with dysfunction of myelination by Shati/Nat8L deficit in mice

  Nitta, A. (Speaker)

  2018/07/01 → 2018/07/06

  Activity: Talk or presentation › Oral presentation

• Behavioral impairments in SHATI/NAT8L “NAA synthetase” knockout mice were ameliorate by acetate treatment

  Nitta, A. (Speaker)

  2016/11/25

  Activity: Talk or presentation › Oral presentation

• Behavioral impairment via delay myelination development in the prefrontal cortex of SHATI/NAT8L knockout mice

  Nitta, A. (Speaker)

  2018/06/16 → 2018/06/19

  Activity: Talk or presentation › Oral presentation

• Berberine-induced sensitization of metastatic breast cancer to TRAIL treatment

  Yokoyama, S. (Speaker)

  2012/09/19 → 2012/09/21

  Activity: Talk or presentation › Oral presentation

• Berberine-induced sensitization of metastatic breast cancer to TRAIL treatment

  Hayakawa, Y. (Speaker)

  2012/09/19 → 2012/09/21

  Activity: Talk or presentation › Oral presentation

• Bevacizumab投与の非小細胞肺癌における Renin-Angiotensin系阻害薬の蛋白尿低減効果

  Ihara, D. (Speaker)

  2015/10

  Activity: Talk or presentation › Oral presentation

• bFGFの脳室内投与が引き起こす脳形成異常とその解析

  Nitta, A. (Speaker)

  1999/03/29 → 1999/03/31

  Activity: Talk or presentation › Oral presentation

• bFGFの脳室内投与による細胞分化異常とその解析

  Nitta, A. (Speaker)

  1999/06/05

  Activity: Talk or presentation › Oral presentation

• bFGFの脳室内投与による細胞分化異常とその解析

  Nitta, A. (Speaker)

  1999/09/15 → 1999/09/17

  Activity: Talk or presentation › Oral presentation

• BINOL 構造を含むキラルなピリジンーアセチレンーフェノール大環状分子による天然糖の不斉識別

  Ohishi, Y. (Speaker)

  2019/06/01

  Activity: Talk or presentation › Oral presentation

• Bioisosteric Approach for Development of Multifunctional Bio-Probes

  Chiba, J. (Speaker)

  2011/10/16 → 2011/10/21

  Activity: Talk or presentation › Oral presentation

• Biologically active novel branched pyrrolidines: synthesis of isoDAB and isoLAB.

  Kato, A. (Speaker)

  2010/12/15 → 2010/12/20

  Activity: Talk or presentation › Oral presentation

• Bioluminescent imaging of inflammatory tissue microenvironment in 4T1 breast cancer model

  Hayakawa, Y. (Speaker)

  2012/09/19 → 2012/09/21

  Activity: Talk or presentation › Oral presentation

• Biosynthesis of 2-alkylquinolone in the medicinal plant Evodia rutaecarpa

  Morita, H. (Speaker)

  2018/11/05

  Activity: Talk or presentation › Oral presentation

• Blockade of mineralocorticoid receptor ameliorates glucose metabolism and steatohepatitis in a novel mice model of non-alcoholic steatohepatitis.

  Tsuneki, H. (Speaker)

  2011/11/10 → 2011/11/12

  Activity: Talk or presentation › Oral presentation

• Blockade of mineralocorticoid receptor ameliorates glucose metabolism and steatohepatitis in a novel mice model of non-alcoholic steatohepatitis.

  Wada, T. (Speaker)

  2011/11/10 → 2011/11/12

  Activity: Talk or presentation › Oral presentation

• Blockade of mineralocorticoid receptor ameliorates glucose metabolism and steatohepatitis in a novel mice model of non-alcoholic steatohepatitis.

  Sasaoka, T. (Speaker)

  2011/11/10 → 2011/11/12

  Activity: Talk or presentation › Oral presentation

• Blockade of mineralocorticoid receptor improves insulin resistance and steatohepatitis in a novel mouse model of non-alchoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

  Wada, T. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Blockade of mineralocorticoid receptor improves insulin resistance and steatohepatitis in a novel mouse model of non-alchoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

  Tsuneki, H. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Blockade of mineralocorticoid receptor improves insulin resistance and steatohepatitis in a novel mouse model of non-alchoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

  Sasaoka, T. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Blockade of PDGF receptors ameliorates adipocyte dysfunctions and improves glucose metabolisms in diabetic db/db mice.

  Wada, T. (Speaker)

  2014/09/25 → 2014/09/28

  Activity: Talk or presentation › Oral presentation

• Brain-derived neurotrophic factor prevents neuronal cell death induced by corticosterone.

  Nitta, A. (Speaker)

  1997/12/01 → 1997/12/04

  Activity: Talk or presentation › Oral presentation

• Brain-derived neurotrophic factor prevents neuronal cell death induced by corticosterone.

  Nitta, A. (Speaker)

  1997/03

  Activity: Talk or presentation › Oral presentation

• Brain signaling of long-acting insulin analogues glargine and detemir for the regulation of glucose metabolism and learning/memory in mice.

  Tsuneki, H. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Brain signaling of long-acting insulin analogues glargine and detemir for the regulation of glucose metabolism and learning/memory in mice.

  Wada, T. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• Brain signaling of long-acting insulin analogues glargine and detemir for the regulation of glucose metabolism and learning/memory in mice.

  Sasaoka, T. (Speaker)

  2011/06/24 → 2011/06/28

  Activity: Talk or presentation › Oral presentation

• b 生体リズムを基盤とした抗リウマチ薬の至適投与法の構築 /b

  To, H. (Speaker)

  2016

  Activity: Talk or presentation › Oral presentation

• C1位カルボキシ基の誘導化によるシアル酸アナローグの開発

  Chiba, J. (Speaker)

  2014/03/27 → 2014/03/30

  Activity: Talk or presentation › Oral presentation

• CaMK IVノックアウトマウスにおける痛覚伝達機序の解析．

  Uta, D. (Speaker)

  2006/06/10 → 2006/06/11

  Activity: Talk or presentation › Oral presentation

• CaMKIVノックアウトマウスを用いた行動薬理的および電気生理学的検討．

  Uta, D. (Speaker)

  2008/10/03 → 2008/10/04

  Activity: Talk or presentation › Oral presentation

• Candidate genes or compounds for therapeutic tools against methamphetamine and/or morphine-induced dependence.

  Nitta, A. (Speaker)

  2003/08/19 → 2003/08/23

  Activity: Talk or presentation › Oral presentation

• Candidate proteins or small compounds for therapeutic tools against methamphetamine and/or morphine-induced dependence.

  Nitta, A. (Speaker)

  2003/07/31 → 2003/08/01

  Activity: Talk or presentation › Oral presentation

• Carbocation-promoted Intramolecular [3+2] Azide-Olefin Cycloaddition: Synthesis of Unsaturated Imines and Iminium Alkaloid

  Tanimoto, H. (Speaker)

  2012/07/03

  Activity: Talk or presentation › Oral presentation

• Carbocation-promoted Intramolecular Azide-Olefin Cycloaddition: Efficient Synthesis of α,β-Unsaturated Imines and alkaloid

  Tanimoto, H. (Speaker)

  2012/11/14

  Activity: Talk or presentation › Oral presentation

• Casuarine誘導体の各種グリコシダーゼに対する阻害活性と構造活性相関

  Shinzawa, K. (Speaker)

  2022/03/28

  Activity: Talk or presentation › Oral presentation

• Catalytic asymmetric syntheses and biological evaluations of α-1-C-substituted L-iminofuranose derivatives as α-glucosidase inhibitor

  Kato, A. (Speaker)

  2015/12/15 → 2015/12/20

  Activity: Talk or presentation › Oral presentation

• CB1受容体を介した薬物依存に対する扁 桃体の関わり

  Asano, T. (Speaker)

  2020/11/15

  Activity: Talk or presentation › Oral presentation

• CCL-1の疼痛発現との連関、および神経細胞-グリア細胞連関の解明

  Uta, D. (Speaker)

  2012/06/02 → 2012/06/03

  Activity: Talk or presentation › Oral presentation

• CCL-1の疼痛発現との連関、および神経細胞-グリア細胞連関の解明.

  Uta, D. (Speaker)

  2012/06

  Activity: Talk or presentation › Oral presentation

• Effects of Cistanche tubulosa extract on motor function in ossification of posterior longitudinal ligament model mice

  Suyama, M. (Speaker), Yang, X. (Speaker), Nomoto, K. (Speaker) & Tohda, C. (Speaker)

  2021/09/30 → 2021/10/01

  Activity: Talk or presentation › Oral presentation

• Central and peripheral estrogen differentially ameliorates impaired glucose metabolism in postmenopausal obese mice model.

  Wada, T. (Speaker)

  2012/06/08 → 2012/06/12

  Activity: Talk or presentation › Oral presentation